Clinical Trial: Identifying Predictors Of Response To Mepolizumab In CRSwNP
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Chronic Rhinosinusitis With Nasal Polyps
Study Type: INTERVENTIONAL
Official Title: Identifying Predictors Of Long-Lasting Response To Mepolizumab In CRSwNP: Is The Disease-Modifying Role Secondary To Restored Anti-Viral Activity Or Enhanced Epithelial Regeneration?
Brief Summary:
The investigators propose a real-world study to assess the mechanism of action of long-lasting response to mepolizumab in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and identify clinically useful predictors of response.Mepolizumab is a monoclonal antibody targeting IL-5 and is approved for use in asthma and CRSwNP.In clinical studies, 12 months of treatment with mepolizumab improved signs and symptoms of CRSwNP and reduced the need for surgery.While several biologic medications targeting…
Read more